UPDATE : Friday, May 17, 2019
상단여백
Fate of Kolon Life Science hangs on Invossa-K test results
The drug authorities will decide the level of a sanction against Kolon Life...
by Lee Hye-seon  |  2019-04-03 18:14
라인
[Special] MSD Korea makes wrong excuse on external monitoring
After Korea Biomedical Review’s exclusive report revealed that MSD Korea co...
by Jeong Sae-im  |  2019-04-03 16:59
라인
GC releases preclinical trial results for immunotherapy candidate at AACR
GC said Wednesday that it has presented the preclinical trial results of MG...
by Lee Han-soo  |  2019-04-03 14:18
라인
Qurient displays immunotherapy candidate at AACR
Qurient said Wednesday that it held a poster session to present the preclin...
by Lee Han-soo  |  2019-04-03 14:18
라인
Kang becomes new CEO of Abbvie Korea
Abbvie Korea said Monday that it has appointed Kang So-young as its new gen...
by Lee Han-soo  |  2019-04-03 10:50
라인
Lilly’s migraine-preventing therapy becomes orphan drug here
The Ministry of Food and Drug Safety (MFDS) announced Monday that it has gi...
by Lee Han-soo  |  2019-04-02 16:09
라인
‘Paternity testing’ would have prevented Invossa debacle
Kolon Life Science’s mislabeling one of the ingredients of Invossa-K, gene ...
by Jeong Sae-im  |  2019-04-02 15:27
라인
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’
MSD Korea’s Self-Assurance program initially aimed to ensure legitimacy, tr...
by Jeong Sae-im  |  2019-04-02 14:45
라인
Kolon apologizes for ‘mislabeled’ ingredient in Invossa
Kolon Life Science apologized Monday for “mislabeling” one of its key compo...
by Lee Han-soo  |  2019-04-01 17:35
라인
ST Pharm unveils pre-clinical trial results for HIV treatment
ST Pharm said Monday that it has presented the pre-clinical trial results f...
by Lee Han-soo  |  2019-04-01 15:39
라인
Argatroban raises bleeding risk in pregnant women
The Korean regulator would add a precaution label to argatroban, a treatmen...
by Lee Hye-seon  |  2019-04-01 15:29
라인
Hanmi launches seborrheic dermatitis treatment
Hanmi Pharmaceutical said Monday that it has launched Dupien, a seborrheic ...
by Lee Han-soo  |  2019-04-01 14:24
라인
[Special] Why doctors got upset with MSD Korea’s monitoring program
MSD Korea said it was running the Self-Assurance program to ensure legitima...
by Jeong Sae-im  |  2019-04-01 14:22
라인
Astellas Korea names Masujima Keita as new CEO
Astellas Korea said Thursday it appointed Masujima Keita as its new chief e...
by Lee Han-soo  |  2019-04-01 11:02
라인
Bayer reports 8th-consecutive-year growth in Asia-Pacific
Bayer Korea said Friday that 2018 was another year of robust growth for its...
by Lee Han-soo  |  2019-04-01 11:02
라인
LG Chem, Sprint to co-develop NASH treatment
LG Chem said Friday that it has signed a contract with Sprint Bioscience to...
by Lee Han-soo  |  2019-04-01 11:01
라인
‘Expanded reimbursement for Prolia to give more options to osteoporosis patients’
Amgen Korea said Friday Prolia (ingredient: denosumab), a biological agent ...
by Lee Han-soo  |  2019-03-29 18:32
라인
Phase-3 trials of Huntington’s chorea treatment approved
The government has granted the nod to go ahead with phase-3 trials on deute...
by Lee Hye-seon  |  2019-03-29 17:24
라인
Il-yang to research Parkinson’s disease in Europe
Il-yang Pharmaceutical said Wednesday that it plans to start full-fledged c...
by Lee Han-soo  |  2019-03-28 16:28
라인
Allergan to resume marketing of macular edema treatment
Allergan Korea said Tuesday that it has started re-marketing Ozurdex (ingre...
by Lee Han-soo  |  2019-03-27 16:55
여백
여백
여백
Back to Top